GAMMA Investing’s Pulse Biosciences PLSE Stock Holding History

GAMMA Investing’s Portfolio PLSE Stock Details PLSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$30.7K	Buy	615 +174	+39%	+$7.34K	﹤0.01%	2674
2026 Q2	$12.2K	Buy	441 +125	+40%	+$2.95K	﹤0.01%	3104
2026 Q1	$6.82K	Buy	316 +209	+195%	+$3.86K	﹤0.01%	3242
2025 Q4	$1.47K	Sell	107 -14	-12%	-$218	﹤0.01%	3692
2025 Q3	$2.14K	Sell	121 -150	-55%	-$2.37K	﹤0.01%	3437
2025 Q2	$4.09K	Sell	271 -104	-28%	-$1.73K	﹤0.01%	3195
2025 Q1	$6.03K	Buy	375 +113	+43%	+$2.11K	﹤0.01%	3006
2024 Q4	$4.56K	Buy	262 +211	+414%	+$3.72K	﹤0.01%	2954
2024 Q3	$895	Buy	+51	New	+$870	﹤0.01%	3285

Other funds holding PLSE

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

LAM

Lewis Asset Management Lafayette, California $294M AUM 25.62% 1-Year Est. Return

CFS

CGC Financial Services Lake Oswego, Oregon $451M AUM 11.72% 1-Year Est. Return

FFO

Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

GAMMA Investing's PLSE Position: Q3 2026 in Review

GAMMA Investing increased its Pulse Biosciences (PLSE) stake by 39% in Q3 2026, buying an estimated $7.34K and bringing the position to 615 shares worth $30.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2674.

GAMMA Investing first reported a position in PLSE in Q3 2024 and has held it in 9 quarters since. 8 funds tracked by Wall St. Rank hold PLSE as of Q3 2026.

GAMMA Investing held 615 shares of Pulse Biosciences worth $30.7K as of Q3 2026.
GAMMA Investing bought 174 Pulse Biosciences shares in Q3 2026, an estimated $7.34K.
Pulse Biosciences made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #2674 holding.
GAMMA Investing first reported a position in Pulse Biosciences in Q3 2024 and has held it in 9 quarters since.
8 funds tracked by Wall St. Rank held Pulse Biosciences as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.